Steatosis News and Research

RSS
NuSI launches groundbreaking clinical study to halt nonalcoholic fatty liver disease in children

NuSI launches groundbreaking clinical study to halt nonalcoholic fatty liver disease in children

Study shows NASH linked to 50% higher death rates compared with NAFLD

Study shows NASH linked to 50% higher death rates compared with NAFLD

Remogliflozin etabonate: A potential treatment option for management of NASH and NAFLD

Remogliflozin etabonate: A potential treatment option for management of NASH and NAFLD

AstraZeneca selects Regulus' RG-125 as clinical candidate for treatment of NASH

AstraZeneca selects Regulus' RG-125 as clinical candidate for treatment of NASH

Scientists develop computer model to predict how liver stores fat

Scientists develop computer model to predict how liver stores fat

Exposure to hormone-disrupting chemicals can cause fatty liver disease, promote obesity

Exposure to hormone-disrupting chemicals can cause fatty liver disease, promote obesity

Mylan gets tentative approval from FDA for two pediatric dosages of abacavir/lamivudine tablets

Mylan gets tentative approval from FDA for two pediatric dosages of abacavir/lamivudine tablets

Component of Glycyrrhiza uralensis plant may thwart development of metabolic disorders

Component of Glycyrrhiza uralensis plant may thwart development of metabolic disorders

Magnetic resonance: A good method for detecting and quantifying fats in the liver

Magnetic resonance: A good method for detecting and quantifying fats in the liver

FDA approves ViiV Healthcare's Triumeq tablets for treatment of HIV-1 infection

FDA approves ViiV Healthcare's Triumeq tablets for treatment of HIV-1 infection

Consumption of probiotics during 30 days helps diminish accumulation of fat in liver

Consumption of probiotics during 30 days helps diminish accumulation of fat in liver

Snacking linked with abdominal fat and fatty liver

Snacking linked with abdominal fat and fatty liver

Studies provide evidence to clarify role of NAFLD as independent risk factor for development of CVD

Studies provide evidence to clarify role of NAFLD as independent risk factor for development of CVD

New data shows curative effects of GFT505 in NASH associated with metabolic disorders

New data shows curative effects of GFT505 in NASH associated with metabolic disorders

Non-alcoholic steatohepatitis (NASH): an interview with Jean-François Mouney, CEO of Genfit

Non-alcoholic steatohepatitis (NASH): an interview with Jean-François Mouney, CEO of Genfit

Metabolic profiling of liver cells suggests new treatments for cirrhosis patients

Metabolic profiling of liver cells suggests new treatments for cirrhosis patients

AP-1 proteins modulate fat accumulation in liver, say researchers

AP-1 proteins modulate fat accumulation in liver, say researchers

Gilead Sciences gets FDA approval for once-daily single tablet HIV-1 regimen Complera

Gilead Sciences gets FDA approval for once-daily single tablet HIV-1 regimen Complera

FDA Advisory Committee recommends metreleptin for treatment of generalized lipodystrophy

FDA Advisory Committee recommends metreleptin for treatment of generalized lipodystrophy

FOXO3 transcription factor may protect against alcohol-induced liver injury

FOXO3 transcription factor may protect against alcohol-induced liver injury